跳至主要内容
临床试验/CTRI/2023/10/058300
CTRI/2023/10/058300尚未招募2 期

To Evaluate the Efficacy of Pathadya Churna inthe Management of Grahani Dosha - A Clinical trial - nil

Dr Kirti Rahul0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age: 18-60 years
  • 2. Patients having pratyatma lakshana of Grahanidosha especially –
  • Atisrushtam or Ativibadhham or Atidravam malapravritti (altered bowel habits),
  • Ama Mala Pravritti (Sticky stool)
  • I.Durgandhita Mala Pravritti (Fowl Smelling stool)
  • II.Pichchhila Mala Pravritti (Mucous mixed stool)
  • Shoona pada kara,
  • Asthi-parva ruka,
  • Louha-ama-gandhi tiktamlodgar
  • Udara Shoola (Abdominal pain)
  • Udara Gaurava (Heaviness in abdomen)
  • Atopa (Bloating)
  • Able and willing to give written informed consent.

排除标准

  • 1. Mixed infection with parasites such as round worms, hook worms etc.
  • 2. Ulcerative colitis, Crohn’s disease, gastric ulcerations and other inflammatory bowel conditions.
  • 3.Infectious disorders like Intestinal tuberculosis etc.
  • 4. Patients with evidence of malignancy.
  • 5. Patents with diabetes mellitus (FBS >126 mg/dl, PP >200 mg/dl), poorly controlled hypertension, Thyroid disorders and any other autoimmune disorders.
  • 6. Amoebic dysentery, acute diarrhea.
  • 7.Lactose intolerance patients.
  • 8.Abuse of drug or alcohol.
  • 9.Presence of other somatic or mental disorder requiring medication.
  • 10.Patients on prolonged medication with NSAIDs, analgesics or any other drugs that may have an influence on the outcome of the study.
  • 11.H/o hypersensitivity to any of the trial drugs or their ingredients.
  • 12.Patients who have completed participation in any other clinical trial during the past 6 months which is interfering with the results of Grahani.
  • 13.Patients with bleeding per rectum.
  • 14. All the types of atisara, Antraja krimija patients and any other conditions interfering with the results of Grahani.

研究者

发起方
Dr Kirti Rahul

相似试验